Revolution Medicines Inc (RVMD)

Precedente Chiudi:

$39.05

Aprire:

$39.05

Volume 24 ore:

922.23K

Capitalizzazione di mercato:

$6.63B

Reddito:

$29.52M

Utile/perdita netta:

$-436.37M

Rapporto P/E:

-11.93

EPS:

-3.26

Flusso di cassa netto:

$-358.30M

1 W Prestazione:

+4.29%

1M Prestazione:

+24.34%

6M Prestazione:

+80.92%

1 anno Prestazione:

+59.74%

Intervallo 1D:

$38.38

$39.31

Portata 52W:

$15.44

$40.21

Revolution Medicines Inc Stock (RVMD) Company Profile

Nome

Revolution Medicines Inc

Settore

Healthcare (1216)

Industria

Biotechnology (698)

Telefono

650-481-6801

Indirizzo

700 Saginaw Drive, Redwood City, CA

Dipendente

100

Cinguettio

Prossima data di guadagno

2024-05-08

Ultimi documenti SEC

RVMD's Discussions on Twitter

Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-05	Aggiornamento	BofA Securities	Neutral → Buy
2024-01-04	Iniziato	Wedbush	Outperform
2023-11-16	Iniziato	Raymond James	Outperform
2023-02-28	Aggiornamento	JP Morgan	Neutral → Overweight
2022-12-14	Iniziato	Needham	Buy
2022-10-21	Iniziato	Oppenheimer	Outperform
2022-05-20	Iniziato	BofA Securities	Neutral
2022-03-01	Aggiornamento	Stifel	Hold → Buy
2021-09-23	Iniziato	Stifel	Hold
2021-08-12	Downgrade	Goldman	Buy → Neutral
2021-05-18	Iniziato	Goldman	Buy
2020-05-21	Iniziato	H.C. Wainwright	Buy
2020-03-09	Iniziato	Cowen	Outperform
2020-03-09	Iniziato	Guggenheim	Buy
2020-03-09	Iniziato	JP Morgan	Neutral

Mostra tutto

Revolution Medicines Inc Borsa (RVMD) Ultime notizie

Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024

GlobeNewswire Inc.

Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

Top 3 Health Care Stocks That May Collapse In Q2

Benzinga

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

GlobeNewswire Inc.

Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins

GlobeNewswire Inc.

Revolution Medicines Inc Azioni (RVMD) Dati Finanziari

Revolution Medicines Inc (RVMD) Reddito 2024

Revolution Medicines Inc (RVMD) Reddito netto 2024

Revolution Medicines Inc (RVMD) Flusso di cassa 2024

Revolution Medicines Inc (RVMD) Utile per azione 2024

Revolution Medicines Inc Azioni (RVMD) insider trading